nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—PTGFR—ciliary body—ocular cancer	0.491	0.596	CbGeAlD
Dinoprostone—SLC22A8—optic choroid—ocular cancer	0.0642	0.0779	CbGeAlD
Dinoprostone—PTGER4—epithelium—ocular cancer	0.036	0.0437	CbGeAlD
Dinoprostone—PTGER4—lymphoid tissue—ocular cancer	0.0278	0.0337	CbGeAlD
Dinoprostone—PTGFR—eye—ocular cancer	0.0267	0.0324	CbGeAlD
Dinoprostone—HPGDS—epithelium—ocular cancer	0.0264	0.032	CbGeAlD
Dinoprostone—PTGIR—epithelium—ocular cancer	0.0215	0.0261	CbGeAlD
Dinoprostone—SLCO3A1—retina—ocular cancer	0.0206	0.025	CbGeAlD
Dinoprostone—SLCO2A1—eye—ocular cancer	0.0206	0.0249	CbGeAlD
Dinoprostone—HPGDS—lymphoid tissue—ocular cancer	0.0203	0.0247	CbGeAlD
Dinoprostone—SLCO2A1—epithelium—ocular cancer	0.0188	0.0228	CbGeAlD
Dinoprostone—SLCO4A1—retina—ocular cancer	0.0187	0.0227	CbGeAlD
Dinoprostone—ABCC5—retina—ocular cancer	0.0186	0.0226	CbGeAlD
Dinoprostone—SLC22A8—eye—ocular cancer	0.0129	0.0157	CbGeAlD
Dinoprostone—SLCO1A2—Metabolism—PSPH—ocular cancer	0.000466	0.00265	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MAML2—ocular cancer	0.000459	0.00261	CbGpPWpGaD
Dinoprostone—ABCC5—NRF2 pathway—TGFB1—ocular cancer	0.000443	0.00251	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—GNA11—ocular cancer	0.000442	0.00251	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TFDP1—ocular cancer	0.000438	0.00249	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—GNA11—ocular cancer	0.000423	0.00241	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—E2F5—ocular cancer	0.000423	0.0024	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PSPH—ocular cancer	0.000421	0.00239	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—RB1—ocular cancer	0.000421	0.00239	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—E2F4—ocular cancer	0.000415	0.00236	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—GNA11—ocular cancer	0.000414	0.00235	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—GNA11—ocular cancer	0.000414	0.00235	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—E2F5—ocular cancer	0.000414	0.00235	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—E2F5—ocular cancer	0.000414	0.00235	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—RB1—ocular cancer	0.000412	0.00234	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—GNAQ—ocular cancer	0.000411	0.00233	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—RBL1—ocular cancer	0.000406	0.00231	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—E2F4—ocular cancer	0.000406	0.00231	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—E2F4—ocular cancer	0.000406	0.00231	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—GNA11—ocular cancer	0.000401	0.00228	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PSPH—ocular cancer	0.000399	0.00227	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—RBL1—ocular cancer	0.000398	0.00226	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—RBL1—ocular cancer	0.000398	0.00226	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—TFDP1—ocular cancer	0.000394	0.00224	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—GNAQ—ocular cancer	0.000394	0.00224	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—GNA11—ocular cancer	0.000391	0.00222	CbGpPWpGaD
Dinoprostone—CYP11A1—Corticotropin-releasing hormone—AKT1—ocular cancer	0.00039	0.00222	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—CDK2—ocular cancer	0.00039	0.00222	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—GNAQ—ocular cancer	0.000385	0.00219	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—GNAQ—ocular cancer	0.000385	0.00219	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—GNA11—ocular cancer	0.000384	0.00218	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MAML2—ocular cancer	0.000377	0.00214	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—GNA11—ocular cancer	0.000376	0.00214	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—GNA11—ocular cancer	0.000376	0.00214	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—GNAQ—ocular cancer	0.000373	0.00212	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PSPH—ocular cancer	0.000365	0.00208	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—GNAQ—ocular cancer	0.000363	0.00206	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—MDM2—ocular cancer	0.000359	0.00204	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—GNAQ—ocular cancer	0.000357	0.00203	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—E2F3—ocular cancer	0.000352	0.002	CbGpPWpGaD
Dinoprostone—CYP1A2—Tryptophan metabolism—MDM2—ocular cancer	0.000351	0.00199	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—GNAQ—ocular cancer	0.00035	0.00199	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—GNAQ—ocular cancer	0.00035	0.00199	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MAML2—ocular cancer	0.000348	0.00198	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—E2F3—ocular cancer	0.000345	0.00196	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—E2F3—ocular cancer	0.000345	0.00196	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PSPH—ocular cancer	0.000341	0.00194	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—HDAC1—ocular cancer	0.000336	0.00191	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000331	0.00188	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—GNA11—ocular cancer	0.000329	0.00187	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TFDP1—ocular cancer	0.000328	0.00186	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—HDAC1—ocular cancer	0.000328	0.00186	CbGpPWpGaD
Dinoprostone—ABCC4—Ectoderm Differentiation—MYC—ocular cancer	0.000322	0.00183	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TFDP1—ocular cancer	0.000321	0.00182	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TFDP1—ocular cancer	0.000321	0.00182	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ocular cancer	0.00032	0.00182	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.00032	0.00182	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MAML2—ocular cancer	0.000313	0.00178	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.000312	0.00178	CbGpPWpGaD
Dinoprostone—ABCC4—NRF2 pathway—TGFB1—ocular cancer	0.000307	0.00174	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—GNAQ—ocular cancer	0.000306	0.00174	CbGpPWpGaD
Dinoprostone—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.000304	0.00173	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—GNA11—ocular cancer	0.000304	0.00173	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CDKN2B—ocular cancer	0.000301	0.00171	CbGpPWpGaD
Dinoprostone—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.000297	0.00169	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.000296	0.00168	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.000288	0.00163	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—GNAQ—ocular cancer	0.000282	0.0016	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—ocular cancer	0.000281	0.0016	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.000281	0.0016	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—E2F1—ocular cancer	0.000276	0.00157	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—HDAC1—ocular cancer	0.000276	0.00157	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MAML2—ocular cancer	0.00026	0.00148	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MAML2—ocular cancer	0.000255	0.00145	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MAML2—ocular cancer	0.000255	0.00145	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—HDAC1—ocular cancer	0.000255	0.00145	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.000251	0.00142	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmission across Chemical Synapses—MDM2—ocular cancer	0.000248	0.00141	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CDKN2B—ocular cancer	0.000247	0.0014	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.000245	0.00139	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ocular cancer	0.000245	0.00139	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—CDK2—ocular cancer	0.000232	0.00132	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmission across Chemical Synapses—MDM2—ocular cancer	0.000231	0.00132	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—HDAC1—ocular cancer	0.000229	0.0013	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—GNA11—ocular cancer	0.000229	0.0013	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CDKN2B—ocular cancer	0.000228	0.0013	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—GNA11—ocular cancer	0.000227	0.00129	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—E2F1—ocular cancer	0.000227	0.00129	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—GNA11—ocular cancer	0.000222	0.00126	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—GNA11—ocular cancer	0.000222	0.00126	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.00022	0.00125	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—EP300—ocular cancer	0.000219	0.00124	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—GNAQ—ocular cancer	0.000213	0.00121	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—GNAQ—ocular cancer	0.000211	0.0012	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—E2F1—ocular cancer	0.000209	0.00119	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—GNAQ—ocular cancer	0.000207	0.00117	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—GNAQ—ocular cancer	0.000207	0.00117	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.000206	0.00117	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CDKN2B—ocular cancer	0.000205	0.00117	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—GNA11—ocular cancer	0.0002	0.00114	CbGpPWpGaD
Dinoprostone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.000193	0.00109	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—TGFB1—ocular cancer	0.00019	0.00108	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—HDAC1—ocular cancer	0.00019	0.00108	CbGpPWpGaD
Dinoprostone—SLC22A2—Neuronal System—MDM2—ocular cancer	0.00019	0.00108	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—HDAC1—ocular cancer	0.000186	0.00106	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—HDAC1—ocular cancer	0.000186	0.00106	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—GNAQ—ocular cancer	0.000186	0.00106	CbGpPWpGaD
Dinoprostone—SLC22A1—Neuronal System—MDM2—ocular cancer	0.000177	0.00101	CbGpPWpGaD
Dinoprostone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.000174	0.000987	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CDKN2B—ocular cancer	0.000171	0.000969	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CDKN2B—ocular cancer	0.000167	0.000949	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CDKN2B—ocular cancer	0.000167	0.000949	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MDM2—ocular cancer	0.000167	0.000949	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PSPH—ocular cancer	0.000159	0.000906	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—TP53—ocular cancer	0.000157	0.000891	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—E2F1—ocular cancer	0.000157	0.00089	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—HRAS—ocular cancer	0.000155	0.000881	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—E2F1—ocular cancer	0.000153	0.000871	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—E2F1—ocular cancer	0.000153	0.000871	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000153	0.00087	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CDKN1B—ocular cancer	0.000152	0.000866	CbGpPWpGaD
Dinoprostone—PTGER4—GPCR downstream signaling—AKT1—ocular cancer	0.000151	0.000857	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.00015	0.000853	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—HRAS—ocular cancer	0.00015	0.000852	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—EP300—ocular cancer	0.000148	0.000838	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GNA11—ocular cancer	0.000147	0.000834	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CCND1—ocular cancer	0.000145	0.000826	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CDKN1A—ocular cancer	0.000141	0.000799	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MDM2—ocular cancer	0.000137	0.000779	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—AKT1—ocular cancer	0.000137	0.000778	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GNAQ—ocular cancer	0.000136	0.000775	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000136	0.000774	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—EP300—ocular cancer	0.000134	0.000761	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GNA11—ocular cancer	0.000133	0.000754	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—AKT1—ocular cancer	0.000132	0.000752	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—EP300—ocular cancer	0.000131	0.000742	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—HRAS—ocular cancer	0.000127	0.000724	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000127	0.000722	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MDM2—ocular cancer	0.000127	0.000719	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GNA11—ocular cancer	0.000126	0.000713	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CDKN1B—ocular cancer	0.000125	0.000711	CbGpPWpGaD
Dinoprostone—PTGER2—GPCR downstream signaling—AKT1—ocular cancer	0.000124	0.000704	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GNAQ—ocular cancer	0.000123	0.000701	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CCND1—ocular cancer	0.000119	0.000679	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—HRAS—ocular cancer	0.000118	0.000668	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GNAQ—ocular cancer	0.000117	0.000663	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—MYC—ocular cancer	0.000117	0.000663	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TGFB1—ocular cancer	0.000116	0.000661	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CDKN1A—ocular cancer	0.000116	0.000657	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CDKN1B—ocular cancer	0.000116	0.000657	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GNA11—ocular cancer	0.000115	0.000653	CbGpPWpGaD
Dinoprostone—PTGER3—GPCR downstream signaling—AKT1—ocular cancer	0.000114	0.000649	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MDM2—ocular cancer	0.000114	0.000646	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TGFB1—ocular cancer	0.000114	0.000645	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—AKT1—ocular cancer	0.000112	0.000639	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CCND1—ocular cancer	0.00011	0.000626	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.00011	0.000626	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—EP300—ocular cancer	0.00011	0.000625	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GNA11—ocular cancer	0.000107	0.000609	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GNAQ—ocular cancer	0.000107	0.000607	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CDKN1A—ocular cancer	0.000107	0.000606	CbGpPWpGaD
Dinoprostone—SLC22A2—Neuronal System—HRAS—ocular cancer	0.000104	0.000593	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CDKN1B—ocular cancer	0.000104	0.00059	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—AKT1—ocular cancer	0.000104	0.00059	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—EP300—ocular cancer	0.000101	0.000577	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GNAQ—ocular cancer	9.97e-05	0.000566	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	9.95e-05	0.000565	CbGpPWpGaD
Dinoprostone—SLC22A1—Neuronal System—HRAS—ocular cancer	9.73e-05	0.000553	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CDKN1A—ocular cancer	9.59e-05	0.000545	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TP53—ocular cancer	9.58e-05	0.000544	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MYC—ocular cancer	9.58e-05	0.000544	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TGFB1—ocular cancer	9.56e-05	0.000543	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MDM2—ocular cancer	9.46e-05	0.000538	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	9.42e-05	0.000535	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TP53—ocular cancer	9.34e-05	0.000531	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MDM2—ocular cancer	9.26e-05	0.000526	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MDM2—ocular cancer	9.26e-05	0.000526	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—HRAS—ocular cancer	9.16e-05	0.000521	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—EP300—ocular cancer	9.12e-05	0.000518	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—HRAS—ocular cancer	8.94e-05	0.000508	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—AKT1—ocular cancer	8.92e-05	0.000507	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MYC—ocular cancer	8.84e-05	0.000502	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TGFB1—ocular cancer	8.82e-05	0.000501	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—HRAS—ocular cancer	8.79e-05	0.000499	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CDKN1B—ocular cancer	8.64e-05	0.000491	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—HRAS—ocular cancer	8.6e-05	0.000489	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—HRAS—ocular cancer	8.6e-05	0.000489	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—AKT1—ocular cancer	8.55e-05	0.000486	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CDKN1B—ocular cancer	8.46e-05	0.000481	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CDKN1B—ocular cancer	8.46e-05	0.000481	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—AKT1—ocular cancer	8.37e-05	0.000475	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—AKT1—ocular cancer	8.37e-05	0.000475	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CCND1—ocular cancer	8.24e-05	0.000468	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—AKT1—ocular cancer	8.09e-05	0.00046	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CCND1—ocular cancer	8.07e-05	0.000458	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CCND1—ocular cancer	8.07e-05	0.000458	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CDKN1A—ocular cancer	7.97e-05	0.000453	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MYC—ocular cancer	7.95e-05	0.000452	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—TGFB1—ocular cancer	7.93e-05	0.00045	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—AKT1—ocular cancer	7.89e-05	0.000448	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TP53—ocular cancer	7.87e-05	0.000447	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CDKN1A—ocular cancer	7.81e-05	0.000443	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CDKN1A—ocular cancer	7.81e-05	0.000443	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—AKT1—ocular cancer	7.76e-05	0.000441	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—EP300—ocular cancer	7.64e-05	0.000434	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—AKT1—ocular cancer	7.6e-05	0.000432	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—AKT1—ocular cancer	7.6e-05	0.000432	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—EP300—ocular cancer	7.59e-05	0.000431	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—HRAS—ocular cancer	7.53e-05	0.000428	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—EP300—ocular cancer	7.43e-05	0.000422	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—EP300—ocular cancer	7.43e-05	0.000422	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TP53—ocular cancer	7.26e-05	0.000413	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—HRAS—ocular cancer	6.94e-05	0.000395	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—EP300—ocular cancer	6.69e-05	0.00038	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—AKT1—ocular cancer	6.64e-05	0.000378	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MYC—ocular cancer	6.61e-05	0.000376	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TGFB1—ocular cancer	6.6e-05	0.000375	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MYC—ocular cancer	6.47e-05	0.000368	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MYC—ocular cancer	6.47e-05	0.000368	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TGFB1—ocular cancer	6.46e-05	0.000367	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TGFB1—ocular cancer	6.46e-05	0.000367	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—HRAS—ocular cancer	6.24e-05	0.000355	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—AKT1—ocular cancer	6.13e-05	0.000348	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—AKT1—ocular cancer	5.51e-05	0.000313	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TP53—ocular cancer	5.43e-05	0.000309	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TP53—ocular cancer	5.32e-05	0.000302	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TP53—ocular cancer	5.32e-05	0.000302	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—HRAS—ocular cancer	5.19e-05	0.000295	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—HRAS—ocular cancer	5.08e-05	0.000289	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—HRAS—ocular cancer	5.08e-05	0.000289	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GNA11—ocular cancer	5.02e-05	0.000285	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—EP300—ocular cancer	4.9e-05	0.000279	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GNAQ—ocular cancer	4.66e-05	0.000265	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—AKT1—ocular cancer	4.62e-05	0.000262	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—AKT1—ocular cancer	4.59e-05	0.000261	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—AKT1—ocular cancer	4.49e-05	0.000255	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—AKT1—ocular cancer	4.49e-05	0.000255	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—EP300—ocular cancer	4.43e-05	0.000252	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—EP300—ocular cancer	4.19e-05	0.000238	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—AKT1—ocular cancer	4.04e-05	0.00023	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—EP300—ocular cancer	3.84e-05	0.000218	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.76e-05	0.000214	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—EP300—ocular cancer	3.58e-05	0.000203	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—AKT1—ocular cancer	2.96e-05	0.000168	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—AKT1—ocular cancer	2.68e-05	0.000152	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—AKT1—ocular cancer	2.53e-05	0.000144	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—AKT1—ocular cancer	2.32e-05	0.000132	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—AKT1—ocular cancer	2.16e-05	0.000123	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—EP300—ocular cancer	1.68e-05	9.52e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AKT1—ocular cancer	1.01e-05	5.75e-05	CbGpPWpGaD
